Patrick J. Gallegos, Pharm.D., BCPS
Reportable Conflicts of Interests: None
Disclosure of Financial Conflicts of Interest: None
Education:
Doctor of Pharmacy
Texas Tech University Health Science Center
School of Pharmacy
Bachelor of Science in Biology
West Texas A & M University
Bachelor of Science: Chemistry
West Texas A & M University
Post Graduate or Residency Training:
Specialty Residency in Pharmacotherapy Practice
ASHP Accredited
Focus in Adult Internal Medicine & Student Education
Texas Tech Health Science Center
School of Pharmacy, Amarillo, Texas
Fellowship and Board Certifications:
Certified BLS & First Aid instructor (AHA)
Board Certified Pharmacotherapy Specialist
ACLS Provider (AHA)
Pharmacist Preceptor Certificate
CPR/AED for the Professional Rescuer (AHA)
Certified Immunization Provider
Current Position or Practice Site:
Assistant Professor of Internal Medicine
Northeastern Ohio Universities College of Medicine
Rootstown, Ohio
Assistant Professor of Pharmacy Practice
Northeastern Ohio Universities College of Pharmacy
Rootstown, Ohio
Pharmacotherapy Specialist in Internal Medicine
Akron General Medical Center
Akron, Ohio
Past Positions and/or Appointments:
Chief Resident – Amarillo & Lubbock Campuses July 2005-July 2006
Texas Tech University Health Science Center
School of Pharmacy
Amarillo, Texas.
Assistant Instructor July 2004-July 2006
Texas Tech University Health Science Center
School of Pharmacy, Amarillo, Texas.
Clinical Staff Pharmacist (Part Time) July 2004-July 2006
McKesson Medication Management
Northwest Texas Healthcare Systems, Amarillo, Texas.
Relief Pharmacist (Part Time) July 2004-present
CVS Pharmacy, Amarillo, Texas.
CVS Pharmacy, Hudson, Ohio
Professional Memberships:
American Association of Colleges of Pharmacy Member
Ohio Society of Health-System Pharmacists Member
Akron Area Society of Hospital Pharmacists
American College of Clinical Pharmacy Member
American Society of Health-System Pharmacists Member
Texas Pharmacy Association Member
Publications:
Gallegos PJ, Frazee L. Use of Anticholinergics in Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia. Pharmacotherapy 2008;28:356-65.
Gallegos PJ, Haase KK, MacLaughlin EJ. Emerging use of Brain Natriuretic Peptide for Monitoring and Titration of Drug Therapy in Patients with Heart Failure. Pharmacotherapy 2008;28:343-55.
Presentations:
“Microbes vs. Mankind, Who Will Survive?” ACPE accredited continuing education program presented to pharmacists at Akron General Medical Center, Akron, Ohio,
May 2007.
“Diagnosis and Treatment Options of Mental Illness,” Presented to local people of Northeastern Ohio with Victoria Sanelli M.D. Northeastern Ohio Universities College of Medicine, Rootstown, Ohio, October 2006.
“Step Up to Success,” Presented to Hispanic high school students motivating them to further their education and exposing them to pharmacy. San Jacinto Baptist Church, Amarillo, Texas, November 2005.
“Medications Used In the Treatment of Cardiology Issues.” Informational cardiology course presented to cardiology patients at Northwest Texas Healthcare Systems. Amarillo, Texas, July & August 2005.
"Medications Used In the Treatment of Diabetes.” Informational diabetes course presented to diabetic patients at Northwest Texas Healthcare Systems, Amarillo, Texas, Monthly.
“The Role of Brain Natriuretic Peptide Monitoring in Acute Heart Failure: A Retrospective Analysis.” ALCALDE XIX: Southwest Leadership Conference for Pharmacy Residents, Fellows and Preceptors. Platform Presentation, Austin, Texas, April 2005.
“Vasopressin vs. Epinephrine in Out-of-Hospital Cardiac Resuscitation.” ACPE Qualifying Presentation. Presented to clinical pharmacists and Pharm.D. Candidates at Texas Tech University Health Sciences Center School of Pharmacy, Amarillo, Texas, May 2004.
“Erectile Dysfunction A Focus on Pharmacological Treatment.” ACPE Qualifying Presentation. Presented to clinical pharmacists and Pharm.D. Candidates at Texas Tech University Health Sciences Center School of Pharmacy, Amarillo, Texas, September 2003.
(Last updated: 2/9/2009)
|
|